Every year on January 12th, we pause to celebrate National Pharmacist Day — a day dedicated to recognizing the vital role pharmacists play in healthcare and as promoters of public health. Often working long hours behind the scenes, these professionals are not only medication experts but also compassionate caregivers who ensure patients receive the safest and most effective treatments.
In addition to all pharmacists, we at C-Path would like to especially recognize two leaders from our team who joined us from the world of pharmacology, Collin Hovinga, PharmD, MS, FCCP, and Alexandre Bétourné, PharmD, PhD. Collin leads our Rare and Orphan Diseases Programs as Vice President and oversees our Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP), as well as the Critical Path for Rare Neurodegenerative Diseases public-private partnership. Dr. Hovinga completed his Bachelor of Science Degree in Biology and Doctor of Pharmacy degrees from Creighton University in Omaha, Nebraska. After which he pursued a Residency and Fellowship in Pediatric Pharmacotherapy with emphasis in Pediatric Neuroscience at the University of Tennessee, Memphis, LeBonheur Children’s Medical Center.
Alex is our Executive Director of the RDCA-DAP initiative, where he leads the team to expand its reach into new disease areas and enhance C-Path’s relationships within the rare disease community. He holds both a PhD and a PharmD from the University of Toulouse in France, has three patents, and has written multiple papers that intersect with several different rare disease areas.
Today we have extra appreciation for Collin and Alex’ leadership and expertise, and especially of their background as pharmacists. All of us have needed the care and expertise of a pharmacist and this is the perfect time to thank them for their critical support of the healthcare industry the next time you need to make a visit.
